Artificial intelligence is playing an increasingly important role in the way new drugs are discovered. It’s radically changing how this process works, and speeding up the development of new therapies.

We Meet: 

Alex Zhavoronkov, CEO at Insilico Medicine 

Mike Nally, CEO at Generate Biomedicines

Credits:

This episode of SHIFT was produced by Jennifer Strong with help from Emma Cillekens. It was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.